Resurge Therapeutics Inc.
Clinical trials sponsored by Resurge Therapeutics Inc., explained in plain language.
-
New prostate drug delivered directly to target
Disease control OngoingThis early study tests a new treatment called RT-310 for men with enlarged prostate (BPH) who have bothersome urinary symptoms. RT-310 is a drug delivered directly into the prostate to reduce side effects. The study will check if it is safe and feasible in 20 men aged 50 to 80.
Phase: PHASE1, PHASE2 • Sponsor: Resurge Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New prostate implant aims to ease bathroom troubles
Disease control OngoingThis early study tests a new device called RT-310, a small implant placed inside the prostate to treat bothersome urinary symptoms from an enlarged prostate. The trial includes 20 men aged 50 to 80 who have not gotten enough relief from medication. The main goal is to check if th…
Phase: PHASE1 • Sponsor: Resurge Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC